Figure 4.
Schema for prospective phase I/II study of hypofractionated PBT, with concurrent chemotherapy, for stage II-III non-small cell lung cancer. This dose-escalation study will enroll 28 patients in the phase I component and 61 in the phase II component. Abbreviations: PCG, Proton Cooperative Group; fx, fractions.